Don't Miss Out

Subscribe to OCA's News & Alerts.

The FDA Effectively Withdraws the Janssen / Johnson & Johnson COVID-19 Shot From the Market

Yesterday the FDA announced it is effectively withdrawing the Janssen/Johnson & Johnson Covid-19 shot from the market (without officially withdrawing it).

From the press release:

Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.

The population for whom “other authorized Covid-19 vaccines are not accessible” and “would otherwise not receive a Covid-19 vaccine” is ZERO. So J&J is done.

The J&J shot is terrible and it is correct to withdraw it. But the explanation given by the FDA does not check out.

The FDA claims that it discovered 60 confirmed cases of thrombocytopenia syndrome and 9 deaths caused by the shot.